Molecular Partners Priced, Swiss Exchange: MOLN.SW

Swiss biotech developing protein therapies for wet AMD and solid tumors.

Industry: Health Care

Latest Trade: $29.40 0.00 (0.0%)

First Day Return: +37.8%

Return from IPO: +26.6%

Industry: Health Care

Swiss biotech developing protein therapies for wet AMD and solid tumors.
more less
IPO News for Molecular Partners
more
IPO Data
IPO File Date 09/24/2014
Offer Price $23.22
Price Range $23.23 - $23.23
Offer Shares (mm) 4.4
Deal Size ($mm) $102
IPO Data
IPO Date 11/04/2014
Offer Price $23.22
Price Range $23.23 - $23.23
Offer Shares (mm) 4.4
Deal Size ($mm) $102
Underwriters
more
Company Data
Headquarters Zurich, Switzerland
Founded 2004
Employees n/a
Website www.molecularpartners.com